Literature DB >> 9025089

The presence of a pseudogene may affect the use of HPRT as an endogenous mRNA control in RT-PCR.

L N Sellner1, G R Turbett.   

Abstract

Semi-quantitative reverse-transcription polymerase chain reaction (RT-PCR) has been used extensively as a tool to measure expression levels of mRNA species. Many commonly used endogenous mRNA control species are known to have genomic pseudogenes, which can confound RT-PCR results if not accounted for. The hypoxanthine phosphoribosyltransferase gene (HPRT) has previously been used as an mRNA control to circumvent these difficulties, since it was believed that no pseudogenes existed. The existence of a pseudogene of HPRT is reported, and researchers are warned that this gene cannot be used as an endogenous mRNA control without taking appropriate precautions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9025089     DOI: 10.1006/mcpr.1996.0068

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  6 in total

1.  Mitochondrial ATP synthase 6 as an endogenous control in the quantitative RT-PCR analysis of clinical cancer samples.

Authors:  C J Gerard; L M Andrejka; R A Macina
Journal:  Mol Diagn       Date:  2000-03

2.  Kinetic Outlier Detection (KOD) in real-time PCR.

Authors:  Tzachi Bar; Anders Ståhlberg; Anders Muszta; Mikael Kubista
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

3.  Falling from grace: HPRT is not suitable as an endogenous control for cancer-related studies.

Authors:  Michelle H Townsend; Abigail M Felsted; Zac E Ence; Stephen R Piccolo; Richard A Robison; Kim L O'Neill
Journal:  Mol Cell Oncol       Date:  2019-02-26

4.  Quantitative reverse transcription-PCR measurement of tissue factor mRNA in glioma.

Authors:  Ming Guan; Bing Su; Yuan Lu
Journal:  Mol Biotechnol       Date:  2002-02       Impact factor: 2.695

5.  Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.

Authors:  Lars O Baumbusch; Simen Myhre; Anita Langerød; Anna Bergamaschi; Stephanie B Geisler; Per E Lønning; Wolfgang Deppert; Irene Dornreiter; Anne-Lise Børresen-Dale
Journal:  Mol Cancer       Date:  2006-10-20       Impact factor: 27.401

6.  Validation of housekeeping gene and impact on normalized gene expression in clear cell renal cell carcinoma: critical reassessment of YBX3/ZONAB/CSDA expression.

Authors:  Sébastien Dupasquier; Anne-Sophie Delmarcelle; Etienne Marbaix; Jean-Pierre Cosyns; Pierre J Courtoy; Christophe E Pierreux
Journal:  BMC Mol Biol       Date:  2014-05-16       Impact factor: 2.946

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.